Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments (Q39744551)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments |
scientific article |
Statements
1 reference
Brief Report: Risk of Gastrointestinal Perforation Among Rheumatoid Arthritis Patients Receiving Tofacitinib, Tocilizumab, or Other Biologic Treatments (English)
1 reference
Jeffrey R Curtis
1 reference
Sasha Bernatsky
1 reference
Fenglong Xie
1 reference
Huifeng Yun
1 reference
23 May 2016
1 reference
1 reference
2612-2617
1 reference
Identifiers
1 reference
1 reference
1 reference